Burka LT, Guengerich FP, Willard RJ, Macdonald TL. Mechanism of cytochrome
P-450 catalysis. Mechanism of N-dealkylation and amine oxide deoxygenation. J Am
Chem Soc 1985;107:2549–2551.
Cashman JR. Monoamine oxidase and flavin-containing monooxygenases. In:
Guengerich FP, editor. Biotransformation, Vol. 3, Comprehensive Toxicology, first
ed. Elsevier Science, Oxford; 1997. p 69–96.
Chandrasena RE, Vatsis KP, Coon MJ, Hollenberg PF, Newcomb M. Hydroxylation
by the hydroperoxy-iron species in cytochrome P450 enzymes. J Am Chem Soc
2004;126:115–126.
Chiba K, Peterson LA, Castagnoli KP, Trevor AJ, Castagnoli N Jr. Studies on the
molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine. Drug Metab Dispos 1985;13:342–347.
Daly AK, Day CP, Aithal GP. CYP2C9 polymorphism and warfarin dose require-
ments. Br J Clin Pharmacol 2002;53:408–409.
Deng Y, Wang Z, Gu S, Ji C, Ying K, Xie Y, Mao Y. Cloning and characterization
of a novel human alcohol dehydrogenase gene (ADHFel). DNA Seq 2002;13:301–
306.
Distlerath LM, Reilly PEB, Martin MV, Davis GG, Wilkinson GR, Guengerich FP.
Purification and characterization of the human liver cytochromes P450 involved in
debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for
genetic polymorphism in oxidative drug metabolism. J Biol Chem 1985;260:9057–
9067.
Duester G, Jarrks J, Felder MR, Holmes RS, Hoijg J-O, Paris X, Plapp BV, Yin S-J,
Jornvall H. Recommended nomenclature for the vetebrate alchol dehydrogenase
gene family. Biochem Pharmacol 1999;58:389–395.
Edenberg HJ, Bosron WF. Alcohol dehydrogenases. In: Guengerich FP, editor.
Biotransformation, Vol. 3, Comprehesive Toxicology, first ed. Elsevier Science,
Oxford; 1997. p 119–131.
Ellis EM, Judah DJ, Neal GE, Hayes JD. An ethoxyquin-inducible aldehyde reductase
from rat liver that metabolizes aflatoxin B 1 defines a subfamily of aldo–keto
reductases. Proc Natl Acad Sci USA 1993;90:10350–10354.
Flynn TG, Kubiseski TJ. Aldo–keto reductases: structure, mechanism, and function.
In: Guengerich FP, editor. Biotransformation, Vol. 3, Comprehensive Toxicology.
first ed. Elsevier Science, Oxford; 1997. p133–147.
Frederick CB, Mays JB, Ziegler DM, Guengerich FP, Kadlubar FF. Cytochrome P450
and flavin-containing monooxygenase-catalyzed formation of the carcinogenN-
hydroxy-2-aminofluorene, and its covalent binding to nuclear DNA. Cancer Res
1982;42:2671–2677.
Gonzalez-Duarte R, Albalat R. Merging protein, gene and genomic data: the evolution
of the MDR-ADH family. Heredity 2005;95:184–197.
Gozukara EM, Belvedere G, Robinson RC, Deutsch J, Coon MJ, Guengerich FP,
Gelboin HV. The effect of epoxide hydratase on benzo[a]pyrene diol epoxide
hydrolysis and binding to DNA and mixed-function oxidase proteins. Mol
Pharmacol 1981;19:153–161.
Guengerich FP. Oxidative cleavage of carboxylic esters by cytochrome P-450. J Biol
Chem 1987;262:8459–8462.
32 OXIDATIVE, REDUCTIVE, AND HYDROLYTIC METABOLISM OF DRUGS